L. Howard (London, United Kingdom), I. Blanco (Barcelona, Spain)
Non-invasive determination of cardiac output – Comparison of inert gas rebreathing and impedance cardiography
F. Trinkmann, M. Berger, D. Haghi, M. Borggrefe, J. J. Kaden, J. Saur (Germany)
|  |
Proportional relations between systolic, diastolic and mean pulmonary artery pressure are explained by vascular properties
T. Kind, T. Faes, A. Vonk-Noordegraaf, N. Westerhof (Amsterdam, Netherlands)
| |
Right ventricular power output is more dependent on glucose uptake than the left ventricle in pulmonary hypertension
G. Ruiter, Y. Y. Wong, M. Lubberink, P. Knaapen, P. Raijmakers, T. Marcus, P. Postmus, N. Westerhof, W. van der Laarse, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
B. Boerrigter, H. Rietema, H. Groepenhoff, P. Postmus, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Non-invasive determination of cardiac output using impedance cardiography (ICG) – Comparison with cardiac magnetic resonance imaging (CMR)
F. Trinkmann, M. Berger, T. Papavassiliu, C. Doesch, S. O. Schoenberg, M. Borggrefe, J. J. Kaden, J. Saur (Germany)
| |
Echocardiographic parameters of right ventricular dysfunction in pulmonary hypertension. Usefulness of speckle tracking longitudinal strain of the right ventricle
B. Lamia, C. Viacroze, N. Lamia, L. C. Molano, D. Mouton-Schleiffer, E. Artaud-Macari, A. Cuvelier, J. F. Muir (Rouen, France)
|  |
Spontaneous haemodynamic variability during right heart catetherisation in patients with pulmonary hypertension
M. Lainscak, F. Sifrer, I. Drinovec (Slovenia)
| |
The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension
W. T. N. Lee, A. Peacock, M. Johnson (Glasgow, United Kingdom)
| |
Comparing the accuracy of inert gas rebreathing (IGR) cardiac output (CO) measurement with invasive measurements in pulmonary hypertension (PH)
R. MacKenzie Ross, M. Toshner, K. Sheares, J. Pepke-Zaba (Cambridge, United Kingdom)
| |
Usefulness of Doppler echocardiography for the hemodynamic evaluation of pulmonary hypertension
B. Lamia, L. C. Molano, C. Viacroze, D. Mouton-Schleiffer, E. Artaud-Macari, A. Cuvelier, J. F. Muir (France)
| |
Echocardiographic tissue Doppler and Holter examination findings in patients with pulmonary sarcoidosis; preliminary study
P. Deeg, M. Dudziak, D. Rawicz-Zegrzda, A. Sternau, A. Dubaniewicz (Poland)
| |
Left ventricular dysfunction with pulmonary pypertension – Cause vs. association
H. Truebel, T. Bugaj, K. Kuhlebrock, H. Sabbah, T. Mondritzki (Wuppertal, Germany; Detroit, United States Of America)
| |
The rehabilitative treatment by Free-aspireÒ can reduce pulmonary hypertension in patients with post- cardiac surgery heart failure. Hemodynamic evaluation of echocardiographic parameters
M. Solinas, G. Mengozzi, A. Di Vincenzo, G. Solarino, M. Ptrilli (Massa, Italy)
| |
The effect of bosentan in occlusive pulmonary hypertension in rats – Role of oxidative and nitrative stress attenuation
O. Rafikova, R. Rafikov, S. Black, S. Tofovic (Pittsburgh, United States Of America)
| |
Bosentan fails to prevent the development of pulmonary arterial hypertension in athymic rats exposed to chronic hypoxia
A. Kratzer, J. Salys, N. Voelkel, L. Tarseviciene-Stewart (Aurora, Richmond, United States Of America)
| |
Bevacizumab administration in monocrotaline induced pulmonary arterial hypertension rat model
C. Karaman, M. Karaman, E. S. Ucan, N. Gokmen, D. Gurel, C. Coker, Y. Adali, O. Yilmaz (Izmir, Turkey)
| |
Role of NFATc3 in chronic hypoxia induced pulmonary hypertension in neonatal mice
R. Bierer, C. Nitta, J. Friedman, L. Gonzalez Bosc (Albuquerque, United States Of America)
| |
Progression of endothelial dysfunction in relationship with development of pathomorphological changes in monocrotalin-induced model pulmonary hypertension in rats
A. Fedorowicz, T. Skorka, A. Jakubowski, M. Walczak, J. Szymura-Oleksiak, S. Chlopicki (Krakow, Poland)
| |
Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells
Y. Kasahara, H. Shimizu, S. Sakao, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi (Japan)
| |
Phosphorylation of HSP27 potentiates endothelial cell death
M. Damarla, B. Kim, T. Simms, H. Yadav, R. Damico, P. Hassoun (Baltimore, United States Of America)
| |